Maravai LifeSciences Holdings, Inc. Current Income Tax Expense (Benefit)
Maravai LifeSciences Holdings, Inc. (MRVI) reported Current Income Tax Expense (Benefit) of -$4.19 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. current income tax expense (benefit) for fiscal 2025 was -$4.19M.
- Maravai LifeSciences Holdings, Inc. current income tax expense (benefit) for fiscal 2024 was -$1.87M, a 260.05% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. current income tax expense (benefit) for fiscal 2023 was $1.17M, a 93.68% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. current income tax expense (benefit) for fiscal 2022 was $18.49M, a 26.56% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | -$4.19M 10-K · filed 2026-02-26 |
| 2024-12-31 | -$1.87M 10-K · filed 2026-02-26 |
| 2023-12-31 | $1.17M 10-K · filed 2026-02-26 |
| 2022-12-31 | $18.49M 10-K · filed 2025-03-18 |
| 2021-12-31 | $14.61M 10-K · filed 2024-02-29 |
| 2020-12-31 | $8.34M 10-K · filed 2023-02-28 |
| 2019-12-31 | $507.00K 10-K · filed 2022-03-01 |